Tumor tracking systems have become an essential component of modern cancer care, enabling clinicians to deliver highly targeted treatment while minimizing damage to surrounding healthy tissue. These systems are designed to monitor tumor position in real time, accounting for patient movement and natural organ motion during therapy. By providing continuous spatial awareness, tumor tracking supports safer and more accurate clinical decision-making.

Cancer tumors rarely remain static. Breathing, digestion, and involuntary muscle movement can shift tumor location during treatment sessions, particularly in cancers affecting the lungs, liver, and abdomen. Tumor tracking systems address this challenge by detecting and responding to motion as it happens. This dynamic feedback allows treatment delivery to adapt instantly, maintaining alignment with the intended target.

In radiation therapy, tumor tracking plays a critical role in improving precision. By ensuring radiation beams remain focused on the tumor despite motion, clinicians can apply therapeutic doses more confidently. This precision…

Zinc Finger Nuclease (ZFN) technology represents one of the earliest breakthroughs in targeted genome editing. Developed to precisely modify DNA at specific locations, ZFNs combine engineered DNA-binding proteins with a DNA-cleaving enzyme, enabling researchers to introduce controlled genetic changes. This technology laid the foundation for modern gene-editing approaches and remains relevant in both research and therapeutic development.

Zinc finger proteins are naturally occurring DNA-binding motifs found in many organisms. Scientists learned to engineer these proteins to recognize specific DNA sequences. When coupled with a nuclease enzyme, typically derived from restriction endonucleases, the resulting construct can cut DNA at a predetermined site. Once the DNA is cut, the cell’s natural repair mechanisms take over, allowing for gene disruption, correction, or insertion.

One of the defining strengths of ZFN technology is its precision. By targeting specific DNA sequences, researchers can modify genes without affecting unrelated regions of the genome. This capability has…

Wilson’s disease is a rare inherited metabolic disorder characterized by excessive accumulation of copper in the body. Because copper is essential only in small amounts, its buildup—particularly in the liver, brain, and eyes—can cause serious and potentially life-threatening complications. Accurate and timely diagnosis is crucial to prevent irreversible organ damage and improve long-term outcomes.

The disease is caused by mutations affecting copper transport and excretion. When copper is not properly eliminated through bile, it accumulates in tissues over time. Early symptoms are often subtle and nonspecific, including fatigue, abdominal discomfort, or mild behavioral changes. These vague signs frequently delay diagnosis, especially in children and young adults.

Diagnostic evaluation for Wilson’s disease involves a combination of clinical assessment, laboratory testing, and imaging. Blood tests measuring ceruloplasmin levels are commonly used, as this copper-binding protein is often reduced in affected individuals. Elevated liver enzymes may indicate hepatic involvement, prompting further investigation.

Urinary…

Vogt–Koyanagi–Harada (VKH) syndrome is a rare autoimmune condition that primarily affects the eyes but can also involve the skin, nervous system, and auditory structures. It occurs when the immune system mistakenly attacks melanocyte-containing tissues, leading to inflammation that can severely impact visual function if not managed promptly.

One of the defining features of VKH syndrome is bilateral uveitis, particularly affecting the posterior segment of the eye. Patients often experience blurred vision, light sensitivity, eye pain, and visual field disturbances. In the early stages, inflammation of the choroid and retina can cause serous retinal detachments, significantly impairing sight.

Beyond ocular symptoms, VKH syndrome may present with neurological manifestations such as headaches, neck stiffness, and tinnitus. Dermatological signs, including vitiligo, alopecia, and poliosis, may develop in later stages, reflecting the systemic nature of the disease. These multisystem effects highlight the complexity of VKH syndrome and the need for coordinated medical care.

Early…